ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $47,000 | -13.0% | 1,148 | +1.2% | 0.01% | -25.0% |
Q2 2020 | $54,000 | +12.5% | 1,134 | 0.0% | 0.01% | -20.0% |
Q1 2020 | $48,000 | -2.0% | 1,134 | 0.0% | 0.01% | +11.1% |
Q4 2019 | $49,000 | +22.5% | 1,134 | 0.0% | 0.01% | +12.5% |
Q3 2019 | $40,000 | +33.3% | 1,134 | 0.0% | 0.01% | +33.3% |
Q2 2019 | $30,000 | -86.2% | 1,134 | -86.1% | 0.01% | -86.7% |
Q1 2019 | $218,000 | +66.4% | 8,134 | 0.0% | 0.04% | +40.6% |
Q4 2018 | $131,000 | -43.3% | 8,134 | -26.9% | 0.03% | -25.6% |
Q3 2018 | $231,000 | +29.1% | 11,134 | -5.5% | 0.04% | +19.4% |
Q2 2018 | $179,000 | -31.2% | 11,784 | +71.2% | 0.04% | -57.1% |
Q3 2017 | $260,000 | +28.7% | 6,884 | +10.4% | 0.08% | +9.1% |
Q1 2017 | $202,000 | – | 6,234 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |